Tetrabenazine Tablet, Coated
Product Images NDC 31722-821

13 FDA label images from Camber Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Tetrabenazine (NDC 31722-821). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (Description)

Description (Description)
Chemical structure of tetrabenazine, showing its molecular framework and functional groups.*
FDA Label Image

Fig1 (Fig1)

Fig1 (Fig1)
A line graph comparing Chorea score changes over 14 study weeks between Tetrabenazine and placebo groups. The x-axis shows study weeks from -1 to 14, with a marked washout period after week 12. The y-axis shows Chorea score change from 1 to -7, with Tetrabenazine showing a greater decrease in score compared to placebo during treatment weeks.*
FDA Label Image

Fig2 (Fig2)

Fig2 (Fig2)
A cumulative percentage curve graph showing change from baseline in chorea score for Tetrabenazine versus placebo groups. The x-axis represents change from baseline, and the y-axis shows cumulative percentage of patients. Markers indicate 3, 6, and 10 points improvements. A small table compares the percentage of patients achieving -3, -6, and -10 point reductions in chorea score for treatment and placebo groups.*
FDA Label Image

Fig3 (Fig3)

FDA Label Image

Fig4 (Fig4)

FDA Label Image

Label1.jpg (Label1)

Label1.jpg (Label1)
Tetrabenazine Tablets 12.5 mg coated tablets label from Camber Pharmaceuticals, Inc. It indicates the strength as 12.5 mg per tablet, contains 56 tablets per bottle, and is for oral use. The label includes storage instructions, manufacturer details, and contact information, as well as caution notes about dispensing and container use.*
FDA Label Image

Label2.jpg (Label2)

Label2.jpg (Label2)
Tetrabenazine Tablets 12.5 mg coating, oral dosage form label from Camber Pharmaceuticals, Inc. The label includes the NDC 31722-821-11 and states a quantity of 112 tablets. It features dosage instructions, storage information, and contact details for the manufacturer and distributor.*
FDA Label Image

Label3.jpg (Label3)

Label3.jpg (Label3)
Packaging label for Tetrabenazine Tablets 12.5 mg coated tablets. The label shows a quantity of 100 (10 x 10) unit dose tablets. It includes storage instructions and a note that the package is not child-resistant. The labeler is Camber Pharmaceuticals, Inc., manufactured by Hetero Labs Limited in India. The label also features the Camber logo and contains a barcode and batch coding information area.*
FDA Label Image

Label4.jpg (Label4)

Label4.jpg (Label4)
Label panel for Tetrabenazine Tablet 12.5 mg from Camber Pharmaceuticals, Inc. The label includes the product name, strength, NDC 31722-821-31, and a barcode. It states the product is manufactured for Camber Pharmaceuticals, Inc. by Hetero Labs Limited, Unit V. The layout shows multiple repeating barcode labels on a sheet.*
FDA Label Image

Label5.jpg (Label5)

Label5.jpg (Label5)
Label for Tetrabenazine Tablets 25 mg, coated oral tablets, manufactured by Camber Pharmaceuticals, Inc. The label includes the NDC 31722-822-56, quantity of 56 tablets, pharmacist dispensing instructions, storage conditions, contact information, and batch coding area with barcode. It also references Hetero Labs, India, as the manufacturer.*
FDA Label Image

Label6.jpg (Label6)

Label6.jpg (Label6)
Label for Tetrabenazine Tablets 25 mg by Camber Pharmaceuticals, Inc. The label states the dosage strength as 25 mg per tablet, with a total of 112 coated tablets in the container. It includes storage instructions, contact information, and a barcode. The label specifies prescription use and notes that the medication guide should be dispensed separately.*
FDA Label Image

Label7.jpg (Label7)

Label7.jpg (Label7)
Tetrabenazine Tablets 25 mg coated tablet label from Camber Pharmaceuticals, Inc. The label displays product name, strength, package size of 100 tablets (10 unit dose blister packs), storage instructions, and manufacturer information. The label is marked for prescription use only with dosage and child safety warnings.*
FDA Label Image

Label8.jpg (Label8)

Label8.jpg (Label8)
Blister packaging label for Tetrabenazine Tablet 25 mg, coated oral tablets. The label shows five individual tablet compartments, each marked with the proprietary name Tetrabenazine, strength 25 mg, and includes a barcode, NDC 31722-822-31. Manufactured for Camber Pharmaceuticals, Inc. by Hetero Labs Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.